-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QdUWm+1+gu37cArxvdUWMLDAh67krCZndJc5y+O8E6C5J4U1XWNi/Jg/JGMJiXh2 z0N8DwwI33iQcI6PEGRJhg== 0001140361-10-034503.txt : 20100820 0001140361-10-034503.hdr.sgml : 20100820 20100820140145 ACCESSION NUMBER: 0001140361-10-034503 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100816 FILED AS OF DATE: 20100820 DATE AS OF CHANGE: 20100820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mintz Hal CENTRAL INDEX KEY: 0001433766 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 101029830 MAIL ADDRESS: STREET 1: 44 WALL STREET STREET 2: SUITE 1603 CITY: NEW YORK STATE: NY ZIP: 10005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berman Ross CENTRAL INDEX KEY: 0001433767 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 101029831 MAIL ADDRESS: STREET 1: 44 WALL STREET STREET 2: SUITE 1603 CITY: NEW YORK STATE: NY ZIP: 10005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAM Management LLC CENTRAL INDEX KEY: 0001463541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 101029832 BUSINESS ADDRESS: STREET 1: 44 WALL STREET STREET 2: SUITE 1603 CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 646-307-4503 MAIL ADDRESS: STREET 1: 44 WALL STREET STREET 2: SUITE 1603 CITY: NEW YORK STATE: NY ZIP: 10005 3 1 doc1.xml FORM 3 X0203 3 2010-08-16 0 0000812796 SOLIGENIX, INC. SNGX 0001463541 BAM Management LLC 1 LIBERTY PLAZA, 27TH FLOOR NEW YORK NY 10006 0 0 1 0 0001433767 Berman Ross 1 LIBERTY PLAZA, 27TH FLOOR NEW YORK NY 10006 0 0 1 0 0001433766 Mintz Hal 1 LIBERTY PLAZA, 27TH FLOOR NEW YORK NY 10006 0 0 1 0 Common Stock 21606092 I See Footnotes Warrants .278 2014-09-27 Common Stock 3952569 I See Footnotes The reported securities are held by investment funds for which BAM Management, LLC serves as investment manager. Mr. Hal Mintz and Mr. Ross Berman serve as managing members of BAM Management, LLC. In their respective capacities, each of BAM Management, LLC, Mr. Hal Mintz and Mr. Ross Berman may be deemed to beneficially own the reported securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. An investment fund for which BAM Management, LLC serves as investment manager holds warrants to purchase up to 3,953,569 shares of Common Stock of Soligenix, Inc. (the "Issuer"), which are subject to a contractual provision limiting the ability to exercise such warrants to the extent that the investment fund and its affiliates would, as a result of such exercise, beneficially own in excess of 4.999% of the Issuer's Common Stock. Accordingly those warrants are currently not exercisable. BAM Management, LLC by Ross Berman, Managing Member 2010-08-19 Ross Berman 2010-08-19 Hal Mintz 2010-08-19 -----END PRIVACY-ENHANCED MESSAGE-----